Estrella Immunopharma Statistics
Total Valuation
ESLA has a market cap or net worth of $67.41 million. The enterprise value is $63.90 million.
Important Dates
The next estimated earnings date is Tuesday, May 26, 2026, after market close.
| Earnings Date | May 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ESLA has 42.67 million shares outstanding. The number of shares has increased by 1.63% in one year.
| Current Share Class | 42.67M |
| Shares Outstanding | 42.67M |
| Shares Change (YoY) | +1.63% |
| Shares Change (QoQ) | +1.96% |
| Owned by Insiders (%) | 1.88% |
| Owned by Institutions (%) | 2.47% |
| Float | 18.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.12
| Current Ratio | 0.12 |
| Quick Ratio | 0.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -258.45% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 126.01% |
| Weighted Average Cost of Capital (WACC) | 7.47% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ESLA has paid $838 in taxes.
| Income Tax | 838 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +58.00% in the last 52 weeks. The beta is 0.58, so ESLA's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | +58.00% |
| 50-Day Moving Average | 1.33 |
| 200-Day Moving Average | 1.39 |
| Relative Strength Index (RSI) | 49.48 |
| Average Volume (20 Days) | 171,254 |
Short Selling Information
The latest short interest is 265,805, so 0.62% of the outstanding shares have been sold short.
| Short Interest | 265,805 |
| Short Previous Month | 626,324 |
| Short % of Shares Out | 0.62% |
| Short % of Float | 1.47% |
| Short Ratio (days to cover) | 1.53 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -13.06M |
| Pretax Income | -13.06M |
| Net Income | -13.06M |
| EBITDA | n/a |
| EBIT | -13.06M |
| Earnings Per Share (EPS) | -$0.35 |
Full Income StatementBalance Sheet
The company has $1.38 million in cash and $6,000 in debt, giving a net cash position of $1.38 million or $0.03 per share.
| Cash & Cash Equivalents | 1.38M |
| Total Debt | 6,000 |
| Net Cash | 1.38M |
| Net Cash Per Share | $0.03 |
| Equity (Book Value) | -10.37M |
| Book Value Per Share | -0.27 |
| Working Capital | -11.87M |
Full Balance SheetCash Flow
| Operating Cash Flow | -1.79M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |